AVR vs TECH · rev $429.0K vs P/E 65, rev $1.22B
Anteris Technologies Global Corp. Common Stock (AVR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AVR revenue for 2025-09-30 was $429.0K. Net income was -$22.2M. Revenue was down 30.6% from 2025-06-30 to 2025-09-30. AVR currently screens at market cap $287.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AVR currently screens at market cap $287.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AVR and TECH stock pages for the full models.
Not investment advice.